These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

849 related articles for article (PubMed ID: 9166783)

  • 21. Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp.
    Chou HT; Kuo TY; Chiang JC; Pei MJ; Yang WT; Yu HC; Lin SB; Chen WJ
    Int J Antimicrob Agents; 2008 Aug; 32(2):130-8. PubMed ID: 18586467
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of variations in the structure of a polyleucine-based alpha-helical transmembrane peptide on its interaction with phosphatidylglycerol bilayers.
    Liu F; Lewis RN; Hodges RS; McElhaney RN
    Biochemistry; 2004 Mar; 43(12):3679-87. PubMed ID: 15035638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Secondary structure and location of a magainin analogue in synthetic phospholipid bilayers.
    Hirsh DJ; Hammer J; Maloy WL; Blazyk J; Schaefer J
    Biochemistry; 1996 Oct; 35(39):12733-41. PubMed ID: 8841117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of the hydrophobicity to net positive charge ratio on antibacterial and anti-endotoxin activities of structurally similar antimicrobial peptides.
    Rosenfeld Y; Lev N; Shai Y
    Biochemistry; 2010 Feb; 49(5):853-61. PubMed ID: 20058937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Membrane binding and pore formation of the antibacterial peptide PGLa: thermodynamic and mechanistic aspects.
    Wieprecht T; Apostolov O; Beyermann M; Seelig J
    Biochemistry; 2000 Jan; 39(2):442-52. PubMed ID: 10631006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative mode of action of novel hybrid peptide CS-1a and its rearranged amphipathic analogue CS-2a.
    Joshi S; Bisht GS; Rawat DS; Maiti S; Pasha S
    FEBS J; 2012 Oct; 279(20):3776-90. PubMed ID: 22883393
    [TBL] [Abstract][Full Text] [Related]  

  • 27. General aspects of peptide selectivity towards lipid bilayers and cell membranes studied by variation of the structural parameters of amphipathic helical model peptides.
    Dathe M; Meyer J; Beyermann M; Maul B; Hoischen C; Bienert M
    Biochim Biophys Acta; 2002 Feb; 1558(2):171-86. PubMed ID: 11779567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure-activity relations of parasin I, a histone H2A-derived antimicrobial peptide.
    Koo YS; Kim JM; Park IY; Yu BJ; Jang SA; Kim KS; Park CB; Cho JH; Kim SC
    Peptides; 2008 Jul; 29(7):1102-8. PubMed ID: 18406495
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure-activity relationships of de novo designed cyclic antimicrobial peptides based on gramicidin S.
    Lee DL; Hodges RS
    Biopolymers; 2003; 71(1):28-48. PubMed ID: 12712499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insertion of magainin into the lipid bilayer detected using lipid photolabels.
    Jo E; Blazyk J; Boggs JM
    Biochemistry; 1998 Sep; 37(39):13791-9. PubMed ID: 9753468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bestowing antifungal and antibacterial activities by lipophilic acid conjugation to D,L-amino acid-containing antimicrobial peptides: a plausible mode of action.
    Avrahami D; Shai Y
    Biochemistry; 2003 Dec; 42(50):14946-56. PubMed ID: 14674771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Solid-state nuclear magnetic resonance relaxation studies of the interaction mechanism of antimicrobial peptides with phospholipid bilayer membranes.
    Lu JX; Damodaran K; Blazyk J; Lorigan GA
    Biochemistry; 2005 Aug; 44(30):10208-17. PubMed ID: 16042398
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Membrane interactions of designed cationic antimicrobial peptides: the two thresholds.
    Glukhov E; Burrows LL; Deber CM
    Biopolymers; 2008 May; 89(5):360-71. PubMed ID: 18186149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of amino acid substitution in amphiphilic alpha-helical peptides on peptide-phospholipid membrane interaction.
    Niidome T; Anzai S; Sonoda J; Tokunaga Y; Nakahara M; Hatakeyama T; Aoyagi H
    J Pept Sci; 1999 Jul; 5(7):298-305. PubMed ID: 10442765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the effects of hydrophobicity, amphiphilicity, and alpha-helicity on the activities of antimicrobial peptides.
    Pathak N; Salas-Auvert R; Ruche G; Janna MH; McCarthy D; Harrison RG
    Proteins; 1995 Jun; 22(2):182-6. PubMed ID: 7567965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction of a magainin-PGLa hybrid peptide with membranes: insight into the mechanism of synergism.
    Nishida M; Imura Y; Yamamoto M; Kobayashi S; Yano Y; Matsuzaki K
    Biochemistry; 2007 Dec; 46(49):14284-90. PubMed ID: 18004888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interplay among folding, sequence, and lipophilicity in the antibacterial and hemolytic activities of alpha/beta-peptides.
    Schmitt MA; Weisblum B; Gellman SH
    J Am Chem Soc; 2007 Jan; 129(2):417-28. PubMed ID: 17212422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimization of the antimicrobial activity of magainin peptides by modification of charge.
    Dathe M; Nikolenko H; Meyer J; Beyermann M; Bienert M
    FEBS Lett; 2001 Jul; 501(2-3):146-50. PubMed ID: 11470274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of membrane activity of amphipathic, antibacterial peptides by slight modifications of the hydrophobic moment.
    Wieprecht T; Dathe M; Krause E; Beyermann M; Maloy WL; MacDonald DL; Bienert M
    FEBS Lett; 1997 Nov; 417(1):135-40. PubMed ID: 9395091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Magainin 2 amide interaction with lipid membranes: calorimetric detection of peptide binding and pore formation.
    Wenk MR; Seelig J
    Biochemistry; 1998 Mar; 37(11):3909-16. PubMed ID: 9521712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.